Compare BIO & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | KEP |
|---|---|---|
| Founded | 1952 | 1961 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Electric Utilities: Central |
| Sector | Industrials | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 17.8B |
| IPO Year | N/A | N/A |
| Metric | BIO | KEP |
|---|---|---|
| Price | $301.82 | $16.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $358.50 | N/A |
| AVG Volume (30 Days) | 165.1K | ★ 393.0K |
| Earning Date | 10-29-2025 | 02-27-2026 |
| Dividend Yield | N/A | ★ 0.28% |
| EPS Growth | N/A | ★ 122.08 |
| EPS | N/A | ★ 9.13 |
| Revenue | $2,557,500,000.00 | ★ $69,245,145,923.00 |
| Revenue This Year | $1.77 | $5.38 |
| Revenue Next Year | $2.30 | $2.36 |
| P/E Ratio | ★ N/A | $3.58 |
| Revenue Growth | N/A | ★ 5.27 |
| 52 Week Low | $211.43 | $6.68 |
| 52 Week High | $373.69 | $18.29 |
| Indicator | BIO | KEP |
|---|---|---|
| Relative Strength Index (RSI) | 40.39 | 46.76 |
| Support Level | $298.02 | $16.60 |
| Resistance Level | $319.50 | $17.30 |
| Average True Range (ATR) | 8.35 | 0.26 |
| MACD | -2.08 | -0.16 |
| Stochastic Oscillator | 12.21 | 3.68 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.